Leśniak, M.; Lipniarska, J.; Majka, P.; Kopyt, W.; Lejman, M.; Zawitkowska, J.
The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies. Vaccines 2023, 11, 277.
https://doi.org/10.3390/vaccines11020277
AMA Style
Leśniak M, Lipniarska J, Majka P, Kopyt W, Lejman M, Zawitkowska J.
The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies. Vaccines. 2023; 11(2):277.
https://doi.org/10.3390/vaccines11020277
Chicago/Turabian Style
Leśniak, Maria, Justyna Lipniarska, Patrycja Majka, Weronika Kopyt, Monika Lejman, and Joanna Zawitkowska.
2023. "The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies" Vaccines 11, no. 2: 277.
https://doi.org/10.3390/vaccines11020277
APA Style
Leśniak, M., Lipniarska, J., Majka, P., Kopyt, W., Lejman, M., & Zawitkowska, J.
(2023). The Role of TRL7/8 Agonists in Cancer Therapy, with Special Emphasis on Hematologic Malignancies. Vaccines, 11(2), 277.
https://doi.org/10.3390/vaccines11020277